Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology

Mh Buch; L Silva Fernandez; L Carmona; D Aletaha; R Christensen; B Combe; P Emery; Gianfranco Ferraccioli; F Guillemin; Tk Kvien; R Landewe; K Pavelka; K Saag; Js Smolen; D Symmons; D Van Der Heijde; J Welling; G Wells; R Westhovens; A Zink; M. Boers

doi:10.1136/annrheumdis-2013-204948

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology

Mh Buch^*, L Silva Fernandez, L Carmona, D Aletaha, R Christensen, B Combe, P Emery, Gianfranco Ferraccioli, F Guillemin, Tk Kvien, R Landewe, K Pavelka, K Saag, Js Smolen, D Symmons, D Van Der Heijde, J Welling, G Wells, R Westhovens, A ZinkM. Boers

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

22 Citazioni (SciVal)

Abstract

Our initiative aimed to produce recommendations on post-randomised controlled trial (RCT) trial extension studies (TES) reporting using European League Against Rheumatism (EULAR) standard operating procedures in order to achieve more meaningful output and standardisation of reports.

Lingua originale	Inglese
pagine (da-a)	963-969
Numero di pagine	7
Rivista	Annals of the Rheumatic Diseases
Volume	74
Numero di pubblicazione	6
DOI	https://doi.org/10.1136/annrheumdis-2013-204948
Stato di pubblicazione	Pubblicato - 2015
Pubblicato esternamente	Sì

All Science Journal Classification (ASJC) codes

Reumatologia
Immunologia e Allergia
Immunologia
Biochimica, Genetica, Biologia Molecolare Generali

Keywords

Advisory Committees
DMARDs (biologic)
Delphi Technique
Epidemiology
Randomized Controlled Trials as Topic
Research Design
Research Report
Rheumatoid Arthritis
Rheumatology

Accesso al documento

10.1136/annrheumdis-2013-204948

Altri file e collegamenti

Cita questo

Buch, M., Silva Fernandez, L., Carmona, L., Aletaha, D., Christensen, R., Combe, B., Emery, P., Ferraccioli, G., Guillemin, F., Kvien, T., Landewe, R., Pavelka, K., Saag, K., Smolen, J., Symmons, D., Van Der Heijde, D., Welling, J., Wells, G., Westhovens, R., ... Boers, M. (2015). Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology. Annals of the Rheumatic Diseases, 74(6), 963-969. https://doi.org/10.1136/annrheumdis-2013-204948

@article{757e46e00896401b8e56434445d88c5c,

title = "Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology",

abstract = "Our initiative aimed to produce recommendations on post-randomised controlled trial (RCT) trial extension studies (TES) reporting using European League Against Rheumatism (EULAR) standard operating procedures in order to achieve more meaningful output and standardisation of reports.",

keywords = "Advisory Committees, DMARDs (biologic), Delphi Technique, Epidemiology, Randomized Controlled Trials as Topic, Research Design, Research Report, Rheumatoid Arthritis, Rheumatology, Advisory Committees, DMARDs (biologic), Delphi Technique, Epidemiology, Randomized Controlled Trials as Topic, Research Design, Research Report, Rheumatoid Arthritis, Rheumatology",

author = "Mh Buch and {Silva Fernandez}, L and L Carmona and D Aletaha and R Christensen and B Combe and P Emery and Gianfranco Ferraccioli and F Guillemin and Tk Kvien and R Landewe and K Pavelka and K Saag and Js Smolen and D Symmons and {Van Der Heijde}, D and J Welling and G Wells and R Westhovens and A Zink and M. Boers",

year = "2015",

doi = "10.1136/annrheumdis-2013-204948",

language = "English",

volume = "74",

pages = "963--969",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "London, United Kingdom: BMJ / British Medical Journal Publishing Group",

number = "6",

}

Buch, M, Silva Fernandez, L, Carmona, L, Aletaha, D, Christensen, R, Combe, B, Emery, P, Ferraccioli, G, Guillemin, F, Kvien, T, Landewe, R, Pavelka, K, Saag, K, Smolen, J, Symmons, D, Van Der Heijde, D, Welling, J, Wells, G, Westhovens, R, Zink, A & Boers, M 2015, 'Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology', Annals of the Rheumatic Diseases, vol. 74, n. 6, pagg. 963-969. https://doi.org/10.1136/annrheumdis-2013-204948

TY - JOUR

T1 - Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology

AU - Buch, Mh

AU - Silva Fernandez, L

AU - Carmona, L

AU - Aletaha, D

AU - Christensen, R

AU - Combe, B

AU - Emery, P

AU - Ferraccioli, Gianfranco

AU - Guillemin, F

AU - Kvien, Tk

AU - Landewe, R

AU - Pavelka, K

AU - Saag, K

AU - Smolen, Js

AU - Symmons, D

AU - Van Der Heijde, D

AU - Welling, J

AU - Wells, G

AU - Westhovens, R

AU - Zink, A

AU - Boers, M.

PY - 2015

Y1 - 2015

N2 - Our initiative aimed to produce recommendations on post-randomised controlled trial (RCT) trial extension studies (TES) reporting using European League Against Rheumatism (EULAR) standard operating procedures in order to achieve more meaningful output and standardisation of reports.

AB - Our initiative aimed to produce recommendations on post-randomised controlled trial (RCT) trial extension studies (TES) reporting using European League Against Rheumatism (EULAR) standard operating procedures in order to achieve more meaningful output and standardisation of reports.

KW - Advisory Committees

KW - DMARDs (biologic)

KW - Delphi Technique

KW - Epidemiology

KW - Randomized Controlled Trials as Topic

KW - Research Design

KW - Research Report

KW - Rheumatoid Arthritis

KW - Rheumatology

KW - Advisory Committees

KW - DMARDs (biologic)

KW - Delphi Technique

KW - Epidemiology

KW - Randomized Controlled Trials as Topic

KW - Research Design

KW - Research Report

KW - Rheumatoid Arthritis

KW - Rheumatology

UR - https://publicatt.unicatt.it/handle/10807/71519

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84934983813&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84934983813&origin=inward

U2 - 10.1136/annrheumdis-2013-204948

DO - 10.1136/annrheumdis-2013-204948

M3 - Article

SN - 0003-4967

VL - 74

SP - 963

EP - 969

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 6

ER -

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo